Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Non-Current Debt (2023 - 2025)

AVITA Medical's Non-Current Debt history spans 3 years, with the latest figure at $42.2 million for Q2 2025.

  • For Q2 2025, Non-Current Debt rose 2.99% year-over-year to $42.2 million; the TTM value through Jun 2025 reached $42.2 million, up 2.99%, while the annual FY2024 figure was $42.2 million, 6.11% up from the prior year.
  • Non-Current Debt reached $42.2 million in Q2 2025 per RCEL's latest filing, up from $41.5 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $42.5 million in Q3 2024 to a low of $39.8 million in Q4 2023.
  • Average Non-Current Debt over 3 years is $41.5 million, with a median of $41.5 million recorded in 2025.
  • Peak YoY movement for Non-Current Debt: increased 6.11% in 2024, then increased 0.39% in 2025.
  • A 3-year view of Non-Current Debt shows it stood at $39.8 million in 2023, then grew by 6.11% to $42.2 million in 2024, then fell by 0.07% to $42.2 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Non-Current Debt are $42.2 million (Q2 2025), $41.5 million (Q1 2025), and $42.2 million (Q4 2024).